col blocks we are bridge builder col blocks
COVID Antworten in den wissenschaftlichen Zeitschriften der Welt


44 Ergebisse       Seite 1

 [1] 
VM Media Sp zo.o. - VMGroup SK: Neurologia i Neurochirurgia Polska
  Original Artikel Datum Titel Autoren   Alle Autoren
1 [GO] 2024―Aug―05 Haemorrhagic intracranial complications associated with vaccine-induced thrombocytopenia or central venous thrombosis after COVID-19 vaccination: postulated underlying mechanisms with literature and case review Mateusz Cheda, Maryla Kuczyńska, Izabela Dąbrowska, Jan Sobstyl, Hanna Szmygin, Agata Zarajczyk, et al. (+3)
2 [GO] 2024―Jan―22 Analysis of seroconversion following COVID-19 vaccination among multiple sclerosis patients treated with disease-modifying therapies in Poland Aleksandra Podlecka-Piętowska, Janusz Sierdziński, Monika Nojszewska, Jakub Stawicki, Halina Bartosik-Psujek, Beata Lech, et al. (+31)
3 [GO] 2023―Jul―25 Cladribine tablets for highly active relapsing-remitting multiple sclerosis in Poland: a real-world, multi-centre, retrospective, cohort study during the COVID-19 pandemic Adam Stępień, Aleksandra Pogoda-Wesołowska, Elżbieta Tokarz-Kupczyk, Agnieszka Słowik, Przemysław Puz, Monika Adamczyk-Sowa, et al. (+7)
4 [GO] 2023―Mai―08 Response to Letter to the Editors regarding article entitled ‘Sex-related patient-reported brain fog symptoms in nonhospitalised COVID-19 patients’ Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, et al. (+3)
5 [GO] 2023―Apr―04 SARS-CoV-2 infection complicated by neuro- or psycho-COVID Sounira Mehri, ArunSundar MohanaSundaram, Sinda Zarrouk, Josef Finsterer
6 [GO] 2023―Apr―04 Response to the Letter to the Editors on the article reviewing the complex subject of ‘Impact of SARS-CoV-2 on the nervous system’ Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska
7 [GO] 2023―Mrz―01 SARS-CoV-2 and the nervous system Alina Kułakowska
8 [GO] 2023―Feb―22 Course of fatigue among patients previously hospitalised due to COVID-19 Iwona Mazurkiewicz, Żaneta Chatys-Bogacka, Joanna Słowik, Magdalena Zdanecka, Andżelika Siwiec-Koźlik, Agnieszka Słowik, et al. (+2)
9 [GO] 2023―Feb―22 Blood-brain barrier function in response to SARS-CoV-2 and its spike protein Łukasz Suprewicz, Krzysztof Fiedoruk, Agata Czarnowska, Marcin Sadowski, Agnieszka Strzelecka, Peter A. Galie, et al. (+3)
10 [GO] 2023―Feb―20 SARS-CoV-2 neurotropism and other possible causes of olfactory disorders in COVID-19 Paweł Sowa, Adam Dadok, Monika Adamczyk-Sowa
11 [GO] 2023―Feb―17 COVID-19 and autoimmune diseases of the nervous system - an update Natalia Morawiec, Bożena Adamczyk, Monika Adamczyk-Sowa
12 [GO] 2023―Feb―17 Sex-related patient-reported brain fog symptoms in non-hospitalised COVID-19 patients Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, Joanna Słowik, Klaudia Nowak, Wojciech Sydor, Barbara Wizner, et al. (+3)
13 [GO] 2023―Feb―17 Incidence and characteristics of post-COVID-19 parkinsonism and dyskinesia related to COVID-19 vaccines Jarosław Dulski, Jarosław Sławek
14 [GO] 2023―Feb―17 Hyperkinetic movement disorders following SARS-CoV-2 infection and vaccination - an update Filip Przytuła, Jarosław Sławek
15 [GO] 2023―Feb―17 Impact of SARS-CoV-2 on the nervous system Agata Czarnowska, Joanna Zajkowska, Alina Kułakowska
16 [GO] 2023―Feb―02 Navigating the landscape of COVID-19 for Multiple Sclerosis patients and clinicians Klara Dyczkowska, Alicja Kalinowska-Łyszczarz
17 [GO] 2023―Feb―02 Incidence of dystonia related to COVID-19 infection Marita F. Thiel, Wolfgang H. Jost
18 [GO] 2023―Feb―02 International study: Global impact of COVID-19 on stroke care - the Polish contribution Anetta Lasek-Bal, Anna Członkowska, Muhammad M. Qureshi, Mohamad Abdalkader, Joao Pedro Marto, Patrik Michel, et al. (+6)
19 [GO] 2022―Dez―14 Electrophysiological and neuroimaging tools to evaluate neurological symptoms, manifestations, and complications in patients with long COVID-19 Gustavo José Luvizutto, Rodrigo Bazan
20 [GO] 2022―Nov―25 High prevalence of electroencephalographic frontal intermittent rhythmic delta activity in patients with moderately severe COVID-19 Magdalena Bosak, Iwona Mazurkiewicz, Dorota Włoch-Kopeć, Jeremiasz Jagiełła, Martyna Woźniak, Maciej Kasprzycki, et al. (+2)
21 [GO] 2022―Nov―25 Immune response to COVID-19 vaccines in patients with multiple sclerosis treated with disease-modifying therapies Waldemar Brola
22 [GO] 2022―Nov―24 Antibodies against SARS-CoV-2 S and N proteins in relapsing-remitting multiple sclerosis patients treated with disease-modifying therapies Joanna Kulikowska, Agata Czarnowska, Monika Gudowska-Sawczuk, Agnieszka Kulczyńska-Przybik, Marcin Bazylewicz, Francois Collins, et al. (+5)
23 [GO] 2022―Jun―27 COVID-19-related headache and innate immune response - a narrative review Marcin Straburzyński, Ewa Kuca-Warnawin, Marta Waliszewska-Prosół
24 [GO] 2022―Mrz―22 Mechanical thrombectomy in COVID-19-associated ischaemic stroke: patient characteristics and outcomes in a single-centre study Katarzyna Sawczyńska, Paweł Wrona, Tomasz Kęsek, Marcin Wnuk, Robert Chrzan, Tomasz Homa, et al. (+4)
25 [GO] 2022―Jan―11 Impact of COVID-19 on incidence and treatment of intracranial aneurysms in Poland: a national study Grzegorz Miękisiak, Justyna Fercho, Samuel D. Pettersson, Tomasz Szmuda, Paweł Słoniewski
26 [GO] 2022―Jan―05 Acute-onset chorea and confusional state in 77-year-old COVID-19 patient: a case report Katarzyna Sawczyńska, Kamil Wężyk, Magdalena Bosak, Jeremiasz Jagiełła, Szymon Andrasik, Alicja Kępińska-Wnuk, et al. (+2)
27 [GO] 2021―Okt―12 Autoimmune mediated hyperkinetic movement disorders in SARS-CoV-2 infection - a systematic review Adam S. Hirschfeld
28 [GO] 2021―Sep―20 Deep brain stimulation procedure complicated by intracerebral infection of DBS lead due to outbreak of COVID-19 pandemic Michał Sobstyl, Angelika Stapińska-Syniec, Anna Kupryjaniuk, Marcin Rylski
29 [GO] 2021―Aug―04 Multiple sclerosis immunomodulatory therapies tested for effectiveness in COVID-19 Bożena Adamczyk, Natalia Morawiec, Monika Arendarczyk, Monika Baran, Krzysztof Wierzbicki, Paweł Sowa, Monika Adamczyk-Sowa
30 [GO] 2021―Aug―04 COVID-19 pandemic year in a sample of Polish myasthenia gravis patients: an observational study Łukasz Rzepiński, Monika Zawadka-Kunikowska
31 [GO] 2021―Jun―07 Two COVID-19-related video-accompanied cases of severe ataxia-myoclonus syndrome Filip Przytuła, Szymon Błądek, Jarosław Sławek
32 [GO] 2021―Mai―13 Neurological symptoms in hospitalised patients with COVID-19 and their association with in-hospital mortality Marcin Wnuk, Katarzyna Sawczyńska, Tomasz Kęsek, Paweł Wrona, Żaneta Chatys-Bogacka, Iwona Mazurkiewicz, et al. (+42)
33 [GO] 2021―Mai―05 4C Mortality Score correlates with in-hospital functional outcome after COVID-19-associated ischaemic stroke Katarzyna Sawczyńska, Marcin Wnuk, Jeremiasz Jagiełła, Tomasz Kęsek, Magdalena Wolska-Sikora, Magdalena Szara-Cichoń, et al. (+19)
34 [GO] 2021―Apr―15 Clinical course and outcome of SARS-CoV-2 infection in multiple sclerosis patients treated with disease-modifying therapies - the Polish experience Agata Czarnowska, Waldemar Brola, Olga Zajkowska, Stanisław Rusek, Monika Adamczyk-Sowa, Katarzyna Kubicka-Bączyk, et al. (+55)
35 [GO] 2021―Mrz―30 Effect of COVID-19 pandemic on stroke admissions and quality of stroke interventional treatment in Masovian Voivodeship Aleksander Dębiec, Marta Bilik, Piotr Piasecki, Adam Stępień, Jacek Staszewski
36 [GO] 2021―Feb―08 COVID-19 mRNA vaccines (Pfizer-BioNTech and Moderna) in patients with multiple sclerosis: a statement by a working group convened by the Section of Multiple Sclerosis and Neuroimmunology of the Polish Neurological Society Monika Nojszewska, Alicja Kalinowska, Monika Adamczyk-Sowa, Alina Kułakowska, Halina Bartosik-Psujek
37 [GO] 2021―Feb―02 Clinical features of neurological patients with coronavirus 2019: an observational study of one centre Justyna Zielińska-Turek, Anna Jasińska, Jolanta Kołakowska, Joanna Szadurska, Dariusz A. Kosior, Małgorzata Dorobek
38 [GO] 2020―Okt―19 B cell targeting therapies in MS patients during the SARS-CoV-2 pandemic - when immunosuppression meets infection? Marcin P. Mycko
39 [GO] 2020―Okt―02 Immunocompromised myasthenia gravis patient not infected with SARS-CoV-2 after close exposure - what is the risk of COVID-19? Łukasz Rzepiński, Sławomir Wawrzyniak, Zdzisław Maciejek
40 [GO] 2020―Jul―23 Significant fall in stroke admissions in the Malopolska Voivodeship of Poland during the COVID-19 pandemic Agnieszka Słowik, Ryszard Nowak, Tadeusz Popiela
41 [GO] 2020―Jul―15 Neurological manifestations of SARS-CoV-2 - a systemic review Stanisław Słyk, Izabela Domitrz
42 [GO] 2020―Jun―25 Response to “Does amantadine have a protective effect against COVID-19?” Philip W. Tipton, Zbigniew K. Wszolek
43 [GO] 2020―Jun―04 Does amantadine have a protective effect against COVID-19? Albert Cortés Borra
44 [GO] 2020―Apr―23 What can Parkinson’s disease teach us about COVID-19? Philip W. Tipton, Zbigniew K. Wszolek
 [1] 

44 Ergebisse       Seite 1


[de][en]

Letzte Änderung 2023―Okt―27 12:08:13 UTC

© Daten-Quadrat 2022       Done in 0.004 sec